Convexity Labs

EPAC

Convexity Analyst · EPAC
Speculativemedium confidenceTactical · no named thesis
Generated Jun 21, 2026

EPAC (Enerpac Tool Group Corp.) Analyst Note

Date: 2026-06-13 Current Price: $36.60

1. Structural Readiness

State: Context-Only Conservative Entry:Breakout Level:Extension:ATR Current: 2.5% (Sub-threshold)

Setup Classification: FORMING (Context-Only)

2. Thesis Layer

Thesis Status: TACTICAL / SETUP-LED There is no named secular thesis attached to EPAC at this date. The investment case is not driven by a macro narrative (e.g., "Energy Transition" or "AI Infrastructure") but is strictly a TACTICAL play based on setup quality and fundamental business health.

Management expectations recorded as of the March 2026 earnings call indicate a focus on "sustainable returns" and "disciplined capital deployment" rather than a specific secular growth narrative. Therefore, conviction must be derived entirely from the quality of the setup structure (the forming coil) and the underlying business fundamentals (product growth vs. service contraction), without inflating the case with external macro themes.

3. The Business

Company Overview: Enerpac Tool Group Corp. is a global enterprise specializing in the production and distribution of industrial products and solutions, operating in over 100 countries. The company is structured into two main operating divisions: Industrial Tools & Services (IT&S) and Other.

  • IT&S Segment (Core): This segment focuses on the design, manufacture, and distribution of branded hydraulic and mechanical tools (hydraulic torque wrenches, cylinders, pumps, bolt tensioners) and provides services including tool rentals, maintenance, and specialized manpower. Key brands include ENERPAC®, HYDRATIGHT®, LARZEP®, SIMPLEX®, and DTA the Smart Move®.
  • *End Markets:* General industrial, refining/petrochemical, MRO, machining & manufacturing, power generation, infrastructure, mining, and oil & gas.
  • *Geographic Mix (Fiscal 2025):* 37% US, 28% Europe, 13% Middle East, 11% Asia, 11% Other.
  • Other Segment: Concentrates on the manufacturing of synthetic ropes and biomedical textiles.

Recent Business Performance (Source: Earnings Transcript 2026-03-26):

  • Product Growth: The IT&S product sales accelerated, growing 6% organically year-over-year. Management noted this represents the "highest growth in products that we have enjoyed in 10 quarters since 2023."
  • Service Contraction: Service sales were down $12 million (19%) year-over-year, with a favorable foreign currency impact of $2 million. This resulted in an organic service sales decline of 22%.
  • Guidance (Full Year 2026):
  • Net Sales: $635M – $650M (representing 1% to 3% organic growth).
  • Adjusted EBITDA: $158M – $163M.
  • Adjusted EPS: $1.85 – $1.92.
  • Growth Composition: Management expects the 1-3% organic sales growth to be composed of "solid product growth in the mid-single-digit range or even a bit better," which is "offset by projected service contraction in the low- to mid-teens range."
  • New Contracts: A five-year contract award with a major oil and gas company in the U.K. North Sea was announced, worth "several million dollars annually," with revenue flow expected to start in Q4 of this fiscal year.
  • Backlog: As of August 31, 2025, substantially all backlog was expected to be filled within twelve months, assuming no significant supply chain constraints.

4. Archetype and Conviction

Archetype: Quality Compounder The company fits the Quality Compounder archetype. This classification is supported by:

  • Margin Expansion & Cash Flow: Management's long-term goal is to create sustainable returns through "expanding our margins, generating strong cash flow, and being disciplined in the deployment of our capital."
  • Capital Discipline: The company repurchased and retired 1,655,307 shares ($65.9 million) in the six months ended February 28, 2026, under the October 2025 authorization.
  • Innovation & R&D: R&D costs increased to $14 million in fiscal 2025 (up from $12M in 2024 and $9M in 2023), indicating a commitment to innovation (e.g., "smart transport solutions" and "infrastructure lifting" demonstrated at recent events).
  • Strategic Acquisitions: The acquisition of DTA The Smart Move, S.A. (completed Sept 4, 2024) expanded capabilities in industrial heavy loads transportation and mobile robotic solutions.

Valuation & Conviction Stack:

  • Financial Spine: Forward consensus EPS for FY1 is $1.895 and FY2 is $2.18.
  • Current Price Context: At $36.60, the stock trades at approximately 19.3x FY1 consensus EPS and 16.8x FY2 consensus EPS.
  • Conviction Factors:
  • *Strength:* The product segment is showing its strongest growth in a decade (6% organic), suggesting a successful pivot or recovery in the core tool business. The "Quality Compounder" status is reinforced by active buybacks and a clear path to margin expansion.
  • *Weakness:* The service segment is contracting significantly (-22% organic), which is dragging down overall top-line growth to a modest 1-3%. The setup is currently "Forming" with sub-threshold volatility (2.5% ATR), indicating a lack of immediate momentum.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

  • Fundamental: A significant deterioration in the product growth rate (falling below the mid-single-digit range) or a further acceleration in service contraction that threatens the EBITDA guidance.
  • Operational: Supply chain constraints preventing the fill of the backlog (which was expected to be filled within 12 months as of Aug 2025).

What Would Strengthen the Case:

  • Technical: A breakout above the current resistance levels (firing the breakout signal) accompanied by an increase in ATR (moving into the 4-6% "sweet spot").
  • Fundamental: Confirmation that the new North Sea contract revenue flows as expected in Q4, or further evidence of product growth accelerating beyond the mid-single-digit range.
  • Capital Allocation: Continued or accelerated share repurchases.

Gaps in Evidence:

  • Margin Details: While EBITDA guidance is provided, specific margin expansion targets or the impact of the DTA acquisition on margins are not detailed in the provided snippets.
  • Service Recovery: There is no explicit timeline or strategy provided for reversing the 22% organic service decline, other than the general guidance of "low- to mid-teens" contraction.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Product sales grew 6% organically (highest in 10 quarters); FY2026 guidance implies 1-3% organic sales growth with EPS of $1.85-$1.92; Active share repurchases of $65.9M in H1 2026. Key risks: Service segment organic decline of 22% offsetting product gains; Setup is in "forming" state with no breakout fired; Current ATR of 2.5% is sub-threshold indicating low volatility momentum. Sizing hint: Position size should be conservative given the unconfirmed setup state and sub-threshold volatility; treat as a partial position pending breakout confirmation. Expected horizon: 3 to 6 months for the setup to resolve into a confirmed breakout or invalidation.

Loading chart...
Exhibit 1: EPAC daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for EPAC.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for EPAC.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: